Telomir Pharmaceuticals IncNASDAQ:TELO
- LAST PRICE4.2300
- TODAY'S CHANGE (%)-0.0100 (-0.2358%)
- Bid / Lots4.0400/ 2
- Ask / Lots4.2500/ 16
- Open / Previous Close4.2500 / 4.2400
- Day Range
- 52 Week Range
- Volume20,592
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TELO |
|---|---|---|
| 09:32 ET | 410 | 4.205 |
| 09:37 ET | 100 | 4.22 |
| 09:39 ET | 800 | 4.2001 |
| 09:42 ET | 200 | 4.2 |
| 09:48 ET | 100 | 4.2 |
| 09:53 ET | 163 | 4.1814 |
| 10:02 ET | 100 | 4.18 |
| 10:08 ET | 311 | 4.1604 |
| 10:09 ET | 100 | 4.16 |
| 10:20 ET | 720 | 4.15 |
| 10:58 ET | 100 | 4.1452 |
| 11:38 ET | 100 | 4.145 |
| 11:56 ET | 1000 | 4.165 |
| 12:28 ET | 249 | 4.19 |
| 12:30 ET | 100 | 4.19 |
| 12:39 ET | 1102 | 4.19 |
| 12:44 ET | 117 | 4.19 |
| 12:48 ET | 1619 | 4.2 |
| 12:50 ET | 300 | 4.2 |
| 12:53 ET | 225 | 4.19 |
| 01:00 ET | 251 | 4.1825 |
| 01:13 ET | 100 | 4.2 |
| 01:18 ET | 143 | 4.2062 |
| 01:20 ET | 899 | 4.18 |
| 02:00 ET | 100 | 4.1845 |
| 02:02 ET | 100 | 4.2 |
| 02:38 ET | 200 | 4.24 |
| 02:45 ET | 500 | 4.235 |
| 02:48 ET | 618 | 4.235 |
| 03:33 ET | 100 | 4.235 |
| 03:46 ET | 100 | 4.23 |
| 04:00 ET | 3104 | 4.23 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Telomir Pharmaceuticals Inc | 125.5M | -6.2x | --- |
Hongchang International Co Ltd | 121.0M | -388.8x | --- |
Global Pharmatech Inc | 138.3M | -3.6x | --- |
Cellectar Biosciences Inc | 82.4M | -0.8x | --- |
Spectral Medical Inc | 118.0M | -9.1x | --- |
Zhong Yuan Bio-Technology Holdings Ltd | 88.2M | 391.4x | --- |
Company Information
Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acid’s (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.
Contact Information
- Headquarters
- 900 West Platt Street, Suite 200TAMPA, FL, United States 33606
- Phone
- 813-864-2562
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Erez Aminov
- Chief Financial Officer
- Michelle Yanez
- Director
- Matthew Del Giudice
- Director
- Ned Macpherson
- Director
- Matthew Whalen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $125.5M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 29.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.69 |
Book Value | $0.12 |
P/E Ratio | -6.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
